CLINICAL RESEARCH โ€” 1.0
Paperwork (Consent, PRO/COA, Diaries,
additional forms, etc.)
Limited geographical location
Patients have to visit a hospital or site, in-
person
Data collection is inconsistent and incomplete
The Evolution of Clinical Trials
www.delvehealth.com
CLINICAL RESEARCH โ€” 2.0
Electronic Forms (eConsent, ePRO/eCOA,
eDiaries, etc.)
No geographical limitations
Patients can schedule virtual visits, at their
convenience
Data collection is seamless and automatic via
wearables & biosensors
The Evolution of Clinical Trials
www.delvehealth.com
Increases the quality of the data
Improves long-term data collection (i.e., after 30
days, data compliance drops to around 30%)
Increases patient diversity
Increases patient compliance and retention, as it
is less time consuming for a patient to participate
www.delvehealth.com
The Benefits of Virtual and
Hybrid Clinical Trials
www.delvehealth.com
The Benefits of Virtual and Hybrid Clinical Trials
Data from
Wearables
Data from
Physicians
Data from
Hospitals
Data from
Imaging
Data from
In-Home Nurses
Data from
Mobile Phones
www.delvehealth.com
The Benefits of Virtual and Hybrid Clinical Trials
Data from
Wearables
Data from
Physicians
Data from
Hospitals
Data from
Imaging
Data from
In-Home Nurses
Data from
Mobile Phones
Single
Technology
Platform
A single platform and central repository
increases the quality of data outcomes
Multiple data points from a diverse set of
patient participants increases the data
quality overall
Multiple data points collected automatically
from patients allows for disease-specific
analytics, unique to your specific study
www.delvehealth.com
The Benefits of Virtual and
Hybrid Clinical Trials
Clinical Trials 1.0โ€”A patient had to come into the
hospital to test how far they could walk, and the
resulting analysis could take a few days
Clinical Trials 2.0โ€”A patient can now test via
wearable or smartphone and more accurate data
is automatically calculated and reported
www.delvehealth.com
Real World Examples of Benefits
Example 1: The Six-Minute Walk
Example 2: eBRAVE_AF Trial
Primary efficacy endpoint, newly diagnosed AF
within six (6) months nearly doubles with use of
technology
Clinical Trials 1.0โ€”0.63% diagnosis rate
Clinical Trials 2.0โ€”1.33% diagnosis rate

Clinical Trials 2.0

  • 1.
    CLINICAL RESEARCH โ€”1.0 Paperwork (Consent, PRO/COA, Diaries, additional forms, etc.) Limited geographical location Patients have to visit a hospital or site, in- person Data collection is inconsistent and incomplete The Evolution of Clinical Trials www.delvehealth.com
  • 2.
    CLINICAL RESEARCH โ€”2.0 Electronic Forms (eConsent, ePRO/eCOA, eDiaries, etc.) No geographical limitations Patients can schedule virtual visits, at their convenience Data collection is seamless and automatic via wearables & biosensors The Evolution of Clinical Trials www.delvehealth.com
  • 3.
    Increases the qualityof the data Improves long-term data collection (i.e., after 30 days, data compliance drops to around 30%) Increases patient diversity Increases patient compliance and retention, as it is less time consuming for a patient to participate www.delvehealth.com The Benefits of Virtual and Hybrid Clinical Trials
  • 4.
    www.delvehealth.com The Benefits ofVirtual and Hybrid Clinical Trials Data from Wearables Data from Physicians Data from Hospitals Data from Imaging Data from In-Home Nurses Data from Mobile Phones
  • 5.
    www.delvehealth.com The Benefits ofVirtual and Hybrid Clinical Trials Data from Wearables Data from Physicians Data from Hospitals Data from Imaging Data from In-Home Nurses Data from Mobile Phones Single Technology Platform
  • 6.
    A single platformand central repository increases the quality of data outcomes Multiple data points from a diverse set of patient participants increases the data quality overall Multiple data points collected automatically from patients allows for disease-specific analytics, unique to your specific study www.delvehealth.com The Benefits of Virtual and Hybrid Clinical Trials
  • 7.
    Clinical Trials 1.0โ€”Apatient had to come into the hospital to test how far they could walk, and the resulting analysis could take a few days Clinical Trials 2.0โ€”A patient can now test via wearable or smartphone and more accurate data is automatically calculated and reported www.delvehealth.com Real World Examples of Benefits Example 1: The Six-Minute Walk Example 2: eBRAVE_AF Trial Primary efficacy endpoint, newly diagnosed AF within six (6) months nearly doubles with use of technology Clinical Trials 1.0โ€”0.63% diagnosis rate Clinical Trials 2.0โ€”1.33% diagnosis rate